Non-BRAF-targeted therapy, immunotherapy, and combination therapy for melanoma

Author： Tomei Sara   Wang Ena   Delogu Lucia Gemma   Marincola Francesco M   Bedognetti Davide  

Publisher： Informa Healthcare

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.14, Iss.5, 2014-05, pp. : 663-686

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Melanoma: Surface markers as the first point of targeted delivery of therapeutic genes in multilevel gene therapy

By Pleshkan V.   Zinovyeva M.   Sverdlov E.  

Molecular Biology, Vol. 45, Iss. 3, 2011-06 ,pp. : 375-391

MAIK Nauka/Interperiodica

Access to resources Recommend Favorite

The role of vaccine therapy in the treatment of melanoma

By Lens Marko  

Expert Opinion on Biological Therapy, Vol. 8, Iss. 3, 2008-03 ,pp. : 315-323

Informa Healthcare

Access to resources Recommend Favorite

Vascular-targeted cancer gene therapy

By Dougherty Graeme J   Davis Peter D   Dougherty Shona T  

Expert Opinion on Biological Therapy, Vol. 4, Iss. 12, 2004-12 ,pp. : 1911-1920

Informa Healthcare

Access to resources Recommend Favorite

Targeted therapy for NSCLC with driver mutations

By Minuti Gabriele   D'Incecco Armida   Cappuzzo Federico  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 10, 2013-10 ,pp. : 1401-1412

Informa Healthcare

Access to resources Recommend Favorite

Herpes simplex virus oncolytic vaccine therapy in melanoma

By Sivendran Shanthi   Pan Michael   Kaufman Howard L   Saenger Yvonne  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 7, 2010-07 ,pp. : 1145-1153

Informa Healthcare

Access to resources Recommend Favorite